Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
Investigating the interactive role of effector and regulatory B cells on promoting autoimmune pathophysiology in severe asthma airways
FY 2020-21
Summary
Asthma is a common respiratory disease in Canada where patients have difficulty in breathing with flare-ups that require hospitalizations and healthcare utilization, all mounting to a significant economic burden. Asthma attacks are mainly caused by recruitment of immune cells to the lungs that cause an inflammatory response. Corticosteroids are used to treat the inflammation, yet 60% of asthmatics remain uncontrolled. Our research has shown that in some asthmatics, airway autoantibodies are generated causing severe inflammation that is unresponsive to current treatments. Autoantibodies are produced by B cells mistakenly against the body's own cells. In a healthy individual a type of B cell, known as a regulatory B cell, would suppress the autoantibody-producing B cells. We believe that in severe asthmatics there is a decrease in factors that normally support regulatory B cells and there is a corresponding increase in autoantibody-producing B cell activity. As a part of my Master's thesis, I will investigate this theory and understand what is contributing to autoantibody production in asthmatics, so that we can find ways of better treating these patients.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
449833
Name
Miyasaki Kate
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the interactive role of effector and regulatory B cells on promoting autoimmune pathophysiology in severe asthma airways
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Airway; Autoantibodies; Autoimmunity; Effector B Cells; Regulatory B Cells; Severe Asthma
Abstract
Asthma is a common respiratory disease in Canada where patients have difficulty in breathing with flare-ups that require hospitalizations and healthcare utilization, all mounting to a significant economic burden. Asthma attacks are mainly caused by recruitment of immune cells to the lungs that cause an inflammatory response. Corticosteroids are used to treat the inflammation, yet 60% of asthmatics remain uncontrolled. Our research has shown that in some asthmatics, airway autoantibodies are generated causing severe inflammation that is unresponsive to current treatments. Autoantibodies are produced by B cells mistakenly against the body's own cells. In a healthy individual a type of B cell, known as a regulatory B cell, would suppress the autoantibody-producing B cells. We believe that in severe asthmatics there is a decrease in factors that normally support regulatory B cells and there is a corresponding increase in autoantibody-producing B cell activity. As a part of my Master's thesis, I will investigate this theory and understand what is contributing to autoantibody production in asthmatics, so that we can find ways of better treating these patients.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Miyasaki, Kate
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~